L3VLUP
ProSign in

SRPT in the 13F filings

Sarepta Therapeutics Inc · CUSIP 803607100

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Mar 2024
the date the book describes
Filed
24 May 2024
latest of these filings; the earliest 13 May 2024
Managers listing it
15
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q4 2023 and Q1 2024; 11 listed it in both
Shares listed
15,500,175
combined, among listed positions
Reported value
$2.0bn
combined, at the quarter end

Among the 93 comparable managers: 9 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing SRPT in Q1 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

15 of 15 holders

ActionFiling
Janus Henderson Group Ltd4,891,417$633m0.35%Trimmed-454,36815 May 2024 (the filing on sec.gov)
Wellington Management Group LLP3,245,798$420m0.07%Trimmed-881,81215 May 2024 (the filing on sec.gov)
Farallon Capital Management LLC2,453,500$318m1.35%Added+1,243,42724 May 2024 (the filing on sec.gov)
Citadel Advisors LLC1,523,077$197munder 0.1%Addedn.a.15 May 2024 (the filing on sec.gov)
Millennium Management LLC874,147$113munder 0.1%Addedn.a.15 May 2024 (the filing on sec.gov)
Two Sigma Advisers LP661,334$86m0.20%Trimmed-44,80015 May 2024 (the filing on sec.gov)
Balyasny Asset Management LLC509,205$66m0.12%Added+10,37613 May 2024 (the filing on sec.gov)
Voloridge Investment Management LLC430,469$56m0.20%Added+71,92115 May 2024 (the filing on sec.gov)
Renaissance Technologies LLC390,278$51m0.08%Trimmed-172,70013 May 2024 (the filing on sec.gov)
Two Sigma Investments LP342,682$44m0.10%Added+40,34215 May 2024 (the filing on sec.gov)
ExodusPoint Capital Management LP105,153$14m0.10%Addedn.a.14 May 2024 (the filing on sec.gov)
PDT Partners LLC35,225$4.6m0.43%Held015 May 2024 (the filing on sec.gov)
Bridgewater Associates LP23,222$3.0munder 0.1%Trimmed-3,16614 May 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP10,712$1.4munder 0.1%Added+2,65315 May 2024 (the filing on sec.gov)
Soros Fund Management LLC3,956$512kunder 0.1%Newnew15 May 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2023 to Q1 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
12 in Q3 2024 to 5 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
SRPT by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20134$52mn.a.n.a.
Q3 20133$62mn.a.n.a.
Q4 20131$4.7mn.a.n.a.
Q1 20141$601kn.a.n.a.
Q2 20143$68mn.a.n.a.
Q3 20142$12mn.a.n.a.
Q4 20141$22mn.a.n.a.
Q1 20151$23mn.a.n.a.
Q2 20152$31mn.a.n.a.
Q3 20155$74mn.a.n.a.
Q4 20152$129mn.a.n.a.
Q1 20161$58mn.a.n.a.
Q2 20163$62mn.a.n.a.
Q3 201610$425mn.a.n.a.
Q4 20165$48mn.a.n.a.
Q1 20176$58mn.a.n.a.
Q2 20174$123mn.a.n.a.
Q3 20176$239mn.a.n.a.
Q4 20178$150mn.a.n.a.
Q1 20188$1.1bnn.a.n.a.
Q2 201820$2.6bnn.a.n.a.
Q3 201810$2.6bnn.a.n.a.
Q4 201813$2.1bnn.a.n.a.
Q1 201911$2.4bnn.a.n.a.
Q2 201911$2.9bnn.a.n.a.
Q3 20198$1.2bnn.a.n.a.
Q4 20199$2.5bnn.a.n.a.
Q1 202011$2.0bnn.a.n.a.
Q2 202016$3.6bnn.a.n.a.
Q3 202011$3.1bnn.a.n.a.
Q4 202013$4.0bnn.a.n.a.
Q1 202111$1.3bnn.a.n.a.
Q2 20219$1.0bnn.a.n.a.
Q3 202110$1.2bnn.a.n.a.
Q4 202113$1.2bnn.a.n.a.
Q1 202212$1.1bnn.a.n.a.
Q2 202213$946mn.a.n.a.
Q3 202221$1.8bnn.a.n.a.
Q4 202221$1.9bnn.a.n.a.
Q1 202320$2.3bnn.a.n.a.
Q2 202313$1.8bnn.a.n.a.
Q3 202319$2.1bnn.a.n.a.
Q4 202312$1.3bn610
Q1 202415$2.0bn95
Q2 202415$2.0bn89
Q3 202412$1.4bn75
Q4 20249$1.2bn45
Q1 202511$665m93
Q2 20255$175m51
Q3 20256$164m23
Q4 20257$298m1615
Q1 20265$281m1811
Q2 20265$132m1416

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

SRPT and LLY →SRPT and JNJ →SRPT and VRTX →Choose a stock to compare with SRPT →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own SRPT, latest filings →Back to the 13F Explorer →